Please login to the form below

Not currently logged in
Email:
Password:

MDD

This page shows the latest MDD news and features for those working in and with pharma, biotech and healthcare.

Biogen signs $3.1bn deal with Sage for potential depression therapies

Biogen signs $3.1bn deal with Sage for potential depression therapies

The collaboration and licence agreement will see Biogen and Sage jointly develop and commercialise zuranolone, an investigational treatment for major depressive disorder (MDD), postpartum depression and other psychiatric disorders. ... Zuranolone is

Latest news

More from news
Approximately 3 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....